MAPT and supranuclear palsy, progressive, 1: Although there was no statistically significant difference between PSP and HC in the regional SUVR comparison, the increase in [11C]HY-2-15 uptake in the tau pathology regions and low uptake in cerebral cortex indicate that [11C]HY-2-15 has potential to image aggregated 4R tau in patients with PSP.